持續血糖監測設備市場（按組件、最終用戶和地區）

Continuous Glucose Monitoring Devices Market, By Component (Sensors, Transmitters, and Receivers), By End User (Hospitals, Home care, and Others), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

出版日期: 2025年07月30日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年連續血糖監測設備市場規模為 78.1 億美元，到 2032 年將達到 151.2 億美元，2025 年至 2032 年的複合年成長率為 9.9%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	78.1億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年	9.90%	2032年預測	151.2億美元

連續血糖監測（CGM）設備是糖尿病患者用來持續監測血糖值的醫療設備。隨著全球糖尿病盛行率的不斷上升，全球對CGM設備的需求也迅速成長。

市場動態

糖尿病盛行率上升、老年人口成長、對 CGM 的需求上升、技術先進設備的採用率增加以及全球人民意識的提高是預計將促進全球連續血糖監測設備市場成長的關鍵因素。

例如，2023年5月，健康科技公司January AI推出了一款基於生成式人工智慧(AI)的全新應用程式，該應用程式可以估算和預測個人對超過320億種食物的血糖反應。此工具只需使用者穿戴一次CGM，即使使用者未使用CGM也能正常運作。該平台旨在持續為用戶提供血糖估計值、預測和關鍵洞察等資訊。使用者還可以獲得關於增加纖維消費量、建議卡路里攝取量、間歇性斷食、減少血糖飆升食物、飯後散步等方面的洞察。

本次調查的主要特點

本報告對全球連續血糖監測設備市場進行了詳細分析，並提供了預測期 2025-2032 的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
它揭示了不同領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
全球連續血糖監測設備市場的主要企業會根據以下參數進行分析，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
預計本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過全球連續血糖監測設備市場分析中使用的各種策略矩陣更輕鬆地做出決策。

介紹
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東南亞國協
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 南非
- 北非
- 中部非洲

第7章競爭態勢

Medtronic
Dexcom, Inc.
Abbott
Novo Nordisk A/S
Ypsomed
GlySens Incorporated
F. Hoffmann-La Roche Ltd.

第 8 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI57

Continuous Glucose Monitoring Devices Market is estimated to be valued at USD 7.81 Bn in 2025 and is expected to reach USD 15.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 7.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.90%	2032 Value Projection:	USD 15.12 Bn

Continuous glucose monitor (CGM) is a medical device used by people with diabetes to monitor blood sugar (glucose) on a continual basis, e.g. people with type I, type II diabetes, or other types of diabetes (e.g. gestational diabetes). Thus, with the increasing prevalence of diabetes across the globe, the demand for CGM devices is also increasing rapidly, worldwide.

Market Dynamics

Increasing prevalence of diabetes, growing geriatric population, increasing demand for continuous glucose monitors (CGM), increasing adoption of technologically advanced devices, and increasing awareness among people across the globe are major factors expected to augment the growth of thelobal continuous glucose monitoring devices market.

For instance, in May 2023, Health tech company, January AI, introduced a new generative artificial intelligence (AI)-enabled app to estimate and predict the glucose response of individuals to more than 32 Bn food items. The tool requires users to wear a CGM only once and it can function even if members are not using a CGM. The platform is designed to provide users with information such as glucose estimates, predictions and key insights on an ongoing basis. Users also receive insights on increasing fibre consumption, calorie recommendations, intermittent fasting, lowering glucose-spiking foods, and getting post-meal walks.

Key features of the study

This report provides in-depth analysis of the global continuous glucose monitoring devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global continuous glucose monitoring devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Medtronic, Dexcom, Inc., Abbott, Novo Nordisk A/S, Ypsomed, GlySens Incorporated, and F. Hoffmann-La Roche Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous glucose monitoring device market.

Market Segmentation

Global Continuous Glucose Monitoring Devices Market, By Component
- Sensors
- Transmitters
- Receivers
Global Continuous Glucose Monitoring Devices Market, By End User
- Hospitals
- Home care
- Others
Global Continuous Glucose Monitoring Devices Market, By Geography
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Medtronic
- Dexcom, Inc.
- Abbott
- Novo Nordisk A/S
- Ypsomed
- GlySens Incorporated
- Hoffmann-La Roche Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of diabetes around the world
- High cost of continuous glucose monitors
- Increasing demand for continuous glucose monitors
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Continuous Glucose Monitoring Devices Market, By Component, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transmitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Receivers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Continuous Glucose Monitoring Devices Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Continuous Glucose Monitoring Devices Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dexcom, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ypsomed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlySens Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views